119 results
Page 2 of 6
8-K
EX-99.1
ymdyk5lm
26 Jul 23
Better Therapeutics Announces $6.7 Million in New Financing at an Average Price of $0.77 per Share
5:11pm
8-K
EX-10.2
1jnrsck
26 Jul 23
Better Therapeutics Announces $6.7 Million in New Financing at an Average Price of $0.77 per Share
5:11pm
8-K
EX-10.1
md4cav byeson64z51ci
26 Jul 23
Better Therapeutics Announces $6.7 Million in New Financing at an Average Price of $0.77 per Share
5:11pm
8-K
EX-99.1
kg1gkdefp266
12 Jul 23
Better Therapeutics Receives FDA Authorization for AspyreRxTM to Treat Adults with Type 2 Diabetes
12:00am
8-K
EX-10.1
i6j2dpxoa
11 May 23
Entry into a Material Definitive Agreement
5:23pm
8-K
EX-99.1
18o 4b4l5
11 May 23
Better Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates
7:33am
8-K
EX-99.1
idofu04h6h96ihf0e
7 Apr 23
Better Therapeutics Announces $6.5MM Private Placement
4:52pm
8-K
EX-10.1
s34j9riy89sqqm2no7z
7 Apr 23
Better Therapeutics Announces $6.5MM Private Placement
4:52pm
8-K
EX-99.1
kgrler
30 Mar 23
Better Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
7:40am
8-K
EX-99.1
1dd589
9 Dec 22
Better Therapeutics Completes Exploratory Trial for Fatty Liver Disease and Announces Positive Topline Results
6:56pm
8-K
EX-99.2
tz2ok6 5uvq88rzzs
9 Dec 22
Better Therapeutics Completes Exploratory Trial for Fatty Liver Disease and Announces Positive Topline Results
6:56pm
424B3
47hjsl3cdcg92z
15 Nov 22
Prospectus supplement
9:56pm
8-K
EX-99.1
t62ivm
14 Nov 22
Better Therapeutics Reports Third Quarter 2022 Financial Results and Provides
4:10pm
8-K
EX-99.1
6z3m2x3shyc8z3p2nfkh
2 Nov 22
Better Therapeutics Appoints Diane Gomez-Thinnes as Chief Commercial Officer
5:07pm
8-K
EX-99.1
gho0f62r9m49m10c5
22 Sep 22
Regulation FD Disclosure
7:41am
8-K
EX-99.1
kovof5bq31m
13 Sep 22
Regulation FD Disclosure
5:32pm